2003•Medical Laboratory SciencesRequires access

Susceptibility testing of Candida species to five antifungal drugs

Jiang Qi

Open publisher page 0 citations

Abstract

Objective To study the in-vitro susceptibilities of Candida species collected from clinical samples to fluconazole, amphotericin B, itraconazole, 5-flucytosine and ketoconazole. Methods 108 isolates of Candida were tested for their minimun inhibitory concentration(MIC) to five antifungal agents by broth microdilution method using Sensititre YeastOne panels. Results In total, there are 8(7.4%), 15(13.9%) and 2(1.9%) isolates displaying resistant to fluconazole, itraconazole, 5-flucytosine respectively. Candida albicans are generally lowest MIC 90 of five drugs among all isolates. Candida glabrata isolates have significantly higher MIC to fluconazole, itraconazole and ketoconazole, comparing with all other Candida species, but still susceptible to amphotericin B and 5-flucytosine. The cross resistance in azoles is also discovered in Candida glabrata. Conclusions Candida species display different resistance to five antifungal drugs.

About this research paper

What this paper is about

Objective To study the in-vitro susceptibilities of Candida species collected from clinical samples to fluconazole, amphotericin B, itraconazole, 5-flucytosine and ketoconazole. Methods 108 isolates of Candida were tested for their minimun inhibitory concentration(MIC) to five antifungal agents by broth microdilution method using Sensititre YeastOne panels. Results In total, there are 8(7.4%), 15(13.9%) and 2(1.9%) isolates displaying resistant to fluconazole, itraconazole, 5-flucytosine respectively. Candida albicans are generally lowest MIC 90 of five drugs among all isolates. Candida glabrata isolates have significantly higher MIC to fluconazole, itraconazole and ketoconazole, comparing with all other Candida species, but still susceptible to amphotericin B and 5-flucytosine. The cross resistance in azoles is also discovered in Candida glabrata. Conclusions Candida species display different resistance to five antifungal drugs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the in-vitro susceptibilities of Candida species collected from clinical samples to fluconazole, amphotericin B, itraconazole, 5-flucytosine and ketoconazole. Methods 108 isolates of Candida were tested for their minimun inhibitory concentration(MIC) to five antifungal agents by broth microdilution method using Sensititre YeastOne panels. Results In total, there are 8(7.4%), 15(13.9%) and 2(1.9%) isolates displaying resistant to fluconazole, itraconazole, 5-flucytosine respectively. Candida albicans are generally lowest MIC 90 of five drugs among all isolates. Candida glabrata isolates have significantly higher MIC to fluconazole, itraconazole and ketoconazole, comparing with all other Candida species, but still susceptible to amphotericin B and 5-flucytosine. The cross resistance in azoles is also discovered in Candida glabrata. Conclusions Candida species display different resistance to five antifungal drugs.

Key concepts: Fluconazole, Ketoconazole, Itraconazole, Flucytosine, Candida glabrata, Amphotericin B, Microbiology, Broth microdilution

Related papers

Back to paper searchBrowse research topicsOriginal source
Susceptibility testing of Candida species to five antifungal drugs — Research Paper | ScholarLens